The protein compositions, or the proteomes, found in human salivary and plasma fluids are compared. From recent experimental work by many laboratories, a catalogue of 2290 proteins found in whole saliva has been compiled. This list of salivary proteins is compared with the 2698 proteins found in plasma. Approximately 27% of the whole-saliva proteins are found in plasma. However, despite this apparent low degree of overlap, the distribution found across Gene Ontological categories, such as molecular function, biological processes, and cellular components, shows significant similarities. Moreover, nearly 40% of the proteins that have been suggested to be candidate markers for diseases such as cancer, cardiovascular disease, and stroke can be found in whole saliva. These comparisons and correlations should encourage researchers to consider the use of saliva to discover new protein markers of disease and as a diagnostic non-proximal fluid to detect early signs of disease throughout the body.
AdamskiMBlackwellTMenonRMartensLHermjakobHTaylorC. (2005). Data management and preliminary data analysis in the pilot phase of the HUPO Plasma Proteome Project. Proteomics5:3246-3261.
2.
AddonaTAAbbatielloSESchillingBSkatesSJManiDRBunkDM. (2009). Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat Biotechnol27:633-641.
3.
AdkinsJNVarnumSMAuberryKJMooreRJAngellNHSmithRD. (2005). Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry. Mol Cell Proteomics1:947-955.
4.
AndersonL (2005). Candidate-based proteomics in the search for biomarkers of cardiovascular disease. J Physiol563(Pt 1):23-60.
5.
AndersonNL (2010). The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum. Clin Chem56:177-185.
6.
AndersonNLPolanskiMPieperRGatlinTTirumalaiRSConradsT. (2005). The human plasma proteome: a nonredundant list developed by combination of four separate sources. Mol Cell Proteomics3:311-326.
7.
BandhakaviSStoneMDOnsongoGVan RiperSKGriffinTJ (2009). A dynamic range compression and three-dimensional peptide fractionation analysis platform expands proteome coverage and the diagnostic potential of whole saliva. J Proteome Res8:5590-5600.
8.
BazzichiLCiregiaFGiustiLBaldiniCGiannacciniGGiacomelliC. (2009). Detection of potential markers of primary fibromyalgia syndrome in human saliva. Proteomics Clin Appl3:1296-1304.
9.
BjorhallKMiliotisTDavidssonP (2005). Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples. Proteomics5:307-317.
10.
CastagnolaMInzitariRRossettiDVOlmiCCabrasTPirasV. (2004). A cascade of 24 histatins (histatin 3 fragments) in human saliva. J Biol Chem279:41436-41443.
11.
CastagnolaMMessanaIInzitariRFanaliCCabrasTMorelliA. (2008). Hypo-phosphorylation of salivary peptidome as a clue to the molecular pathogenesis of autism spectrum disorders. J Proteome Res7:5327-5332.
12.
CastroJJimenez-AlonsoJSabioJMRivera-CivicoFMartin-ArmadaMRodriguezMA. (2003). Salivary and serum beta2-microglobulin and gamma-glutamyl-transferase in patients with primary Sjögren syndrome and Sjögren syndrome secondary to systemic lupus erythematosus. Clin Chim Acta334:225-231.
13.
DennyPHagenFKHardtMLiaoLYanWArellannoM. (2008). The proteomes of human parotid and submandibular/sublingual gland salivas collected as the ductal secretions. J Proteome Res7:1994-2006.
14.
DeutschEWEngJKZhangHKingNLNesvizhskiiAILinB. (2005). Human plasma peptide atlas. Proteomics5:3497-3500.
15.
DrakeRRCazareLHSemmesOJWadsworthJT (2005). Serum, salivary and tissue proteomics for discovery of biomarkers for head and neck cancer. Expert Rev Mol Diagn5:93-100.
16.
FangXYangLWangWSongTLeeCSDeVoeDL. (2007). Comparison of electrokinetic-based multidimensional separations coupled with electrospray ionization-tandem mass spectrometry for characterization of human salivary proteins. Anal Chem79:5785-5792.
17.
FranzmannEJSchroederGLGoodwinWJWeedDTFisherPLokeshwarVB (2003). Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors. Int J Cancer106:438-445.
18.
FranzmannEJReateguiEPPedrosoFPernasFGKarakullukcuBMCarrawayKL. (2007). Soluble CD44 is a potential marker for the early detection of head and neck cancer. Cancer Epidemiol Biomarkers Prev16:1348-1355.
19.
GaoKZhouHZhangLLeeJWZhouQHuS. (2009). Systemic disease-induced salivary biomarker profiles in mouse models of melanoma and non-small cell lung cancer. PLoS ONE4:e5875.
20.
GrisiusMMBermudezDKFoxPC (1997). Salivary and serum interleukin 6 in primary Sjögren’s syndrome. J Rheumatol24:1089-1091.
21.
GuoTRudnickPAWangWLeeCSDeVoeDLBalgleyBM (2006). Characterization of the human salivary proteome by capillary isoelectric focusing/nanoreversed-phase liquid chromatography coupled with ESI-tandem MS. J Proteome Res5:1469-1478.
22.
HaghighatNal-HashimiI (2003). The status of lactoferrin and total iron binding capacity of human parotid saliva in Sjögren’s syndrome. Clin Exp Rheumatol21:485-488.
23.
HardtMThomasLRDixonSENewportGAgabianNProkobholA. (2005a). Toward defining the human parotid gland salivary proteome and peptidome: identification and characterization using 2D SDS-PAGE, ultrafiltration, HPLC and mass spectrometry. Biochemistry44:2885-2899.
24.
HardtMWitkowskaHEWebbSThomasLRDixonSEHallSC. (2005b). Assessing the effects of diurnal variation on the composition of human parotid saliva: quantitative analysis of native peptides using iTRAQ reagents. Anal Chem77:4947-4954.
25.
HuSXieYRamachandranPOgorzalek LooRRLiYLooJA. (2005). Large-scale identification of proteins in human salivary proteome by liquid chromatography/mass spectrometry and two-dimensional gel electrophoresis-mass spectrometry. Proteomics5:1714-1728.
26.
HuSWangJMeijerJLeongSXieYYuT. (2007a). Salivary proteomic and genomic biomarkers for primary Sjögren’s syndome. Arthritis Rheum56:3588-3600.
27.
HuSYuTXieYYangYLiYZhouX. (2007b). Discovery of oral fluid biomarkers for human oral cancer by mass spectrometry. Cancer Genomics Proteomics4:55-64.
28.
HuSArellanoMBoontheungPWangJZhouHJiangJ. (2008). Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res14:6246-6252.
29.
IssaaqHJXiaoZVeenstraTD (2007). Serum and plasma proteomics. Chem Rev107:3601-3620.
30.
KaufmanELamsterIB (2002). The diagnostic application of saliva—a review. Crit Rev Oral Biol Med13:197-212.
31.
LarsenMRJensenSSJakobsenLAHeegaardNH (2007). Exploring the sialome using titanium dioxide chromatography and mass spectrometry. Mol Cell Proteomics6:1778-1787.
32.
LeymarieNBergEAMcCombMEO’ConnorPBGroganJOppenheimFG. (2002). Tandem mass spectrometry for structural characterization of proline rich proteins: application to salivary PRP-3. Anal Chem74:4124-4132.
33.
LiuTQianWJGritsenkoMACampDG2ndMonroeMEMooreRJ. (2005). Human plasma N-glycoproteome analysis by immuno-affinity subtraction, hydrazide chemistry and mass spectrometry. J Proteome Res4:2070-2080.
34.
LoebLMNaffah-MazzacorattiMGPorcionattoMAMartinsJRKouyoumdjianMWeckxLM. (2008). Chrondroitin sulfate and kallikrein in saliva: markers for glossodynia. Int Immunopharmacol8:1056-1058.
35.
MalamudD (1997). Oral diagnostic testing for detecting human immuno-deficiency virus-1 antibodies: a technology whose time has come. Am J Med102:9-14.
36.
MessanaICabrasTInzitariRLupiAZuppiCOlmiC. (2004). Characterization of the human salivary basic proline-rich protein complex by a proteomic approach. J Proteome Res3:792-800.
37.
MeyerPZechelT (2001). Quantitative studies of lysozymes and phosphohexose isomerase in mixed saliva in oral squamous epithelial carcinoma. HNO49:626-629.
38.
NaglerRBaharGShpitzerTFeinmesserR (2006). Concomitant analysis of salivary tumor markers—a new diagnostic tool for oral cancer. Clin Cancer Res12:3979-3984.
39.
NegriLPacchioniDCalabreseFGiacomassoSMastromatteoVFazioM (1988). Serum and salivary CEA and GICA levels in oral cavity tumors. Int J Bio Markers3:107-112.
40.
NissumMKuhfussSHauptmannMObermaierCSukopUWildgruberR. (2007). Two-dimensional separation of human plasma proteins using iterative free-flow electrophoresis. Proteomics7:4218-4227.
41.
OmennGSStatesDJAdamskiMBlackwellTWMenonRHermjakobH. (2005). Overview of the HUPO plasma proteome project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics5:3226-3245.
42.
OppenheimFGSalihESiqueiraWLZhangWHelmerhorstE (2007). Salivary proteome and its genetic polymorphisms. Ann NY Acad Sci1098:22-50.
43.
PickeringVJordanRCSchmidtBL (2007). Elevated salivary endothelin levels in oral cancer patients—a pilot study. Oral Oncol43:37-41.
44.
PieperRGatlinCLMukuskyAJRussoPSSchatzCRMillerSS. (2003). The human serum proteome: display of nearly 3700 chromatographically separated protein spots on two-dimensional electrophoresis gels and identification of 325 distinct proteins. Proteomics3:1345-1364.
45.
RamachandranPBoontheungPXieYSondejMWongDTLooJA (2006). Identification of N-linked glycoproteins in human saliva by glycoprotein capture and mass spectrometry. J Proteome Res5:1493-1503.
46.
RamachandranPBoontheungPPangEYanWWongDTLooJA (2008). Comparison of N-linked glycoproteins in human whole saliva, parotid, submandibular and sublingual glandular secretions identified using hydrazide chemistry and mass spectrometry. Clin Proteomics4:80-104.
47.
RaoPVReddyAPLuXDasariSKrishnaprasadABiggsE. (2009). Proteomic identification of salivary biomarkers of type-2 diabetes. J Proteome Res8:239-245.
48.
RhodusNLHoVMillerCSMyersSOndreyF (2005). NF-kappaB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma. Cancer Detect Prev29:42-45.
49.
RyuOHAtkinsonJCHoehnGTIlleiGGHartTC (2006). Identification of parotid salivary biomarkers in Sjögren’s syndrome by surface enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional gel electrophoresis. Rheumatology (Oxford)45:1077-1086.
50.
SahaSHarrisonSHShenCTangHRadivojacPArnoldRJ. (2008). HIP2: an online database of human plasma proteins from healthy individuals. BMC Med Genomics1:12.
51.
SchenkSSchoenhalsGJde SouzaGMannM (2008). A high confidence, manually validated human blood plasma protein reference set. BMC Med Genomics1:41.
52.
SfriscoPOstuniPBotsiosCAndrettaMOlivieroFPunziL. (2003). Serum and salivary neopterin and interferon-gamma in primary Sjögren’s syndrome. Correlation with clinical, laboratory and histopathological features. Scand J Rheumatol32:74-78.
53.
SondejMDennyPAXieYRamachandranPSiYTakashimaJ. (2009). Glycoprofiling of the human salivary proteome. Clin Proteomics5:52-68.
54.
St JohnMALiYZhaoXDennyPHoCMMontemagnoC. (2004). Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg130:929-935.
55.
StreckfusCBiglerLDellingerTPfeiferMRoseAThigpenJT (1999). CA15–3 and c-erb-2 presence in saliva of women. Clin Oral Investig3:138-143.
56.
StreckfusCBiglerLDellingerTDaiXKingmanAThigpenJT (2000a). The presence of soluble c-erb-2 in saliva and serum among women with breast carcinoma: a preliminary study. Clin Cancer Res6:2363-2370.
57.
StreckfusCBiglerLTucciMThigpenJT (2000b). A preliminary study of CA15–3, c-erb2, epidermal growth factor receptor, cathepsin-D and p53 in saliva among women with breast carcinoma. Cancer Investig18:101-109.
58.
StreckfusCFBiglerLRZwickM (2006). The use of surface enhanced laser desorption/ionization time of flight mass spectrometry to detect putative cancer markers in saliva: a feasibility study. J Oral Pathol Med35:292-300.
59.
TabakLA (2004). Dental, oral, and craniofacial research: the view from the NIDCR. J Dent Res83:196-197.
60.
TakeiMAzuhataTYoshimatuTShigiharaSHashimotoSHorieT. (1995). Increased soluble CD23 molecules in serum/saliva and correlation with the stage of sialoectasis in patients with primary Sjögren’s syndrome. Clin Exp Rheumatol13:711-715.
61.
TirumalaiRSChanKCPrietoDAIssaaqHJConradsTPVeenstraTD (2003). Characterization of the low molecular weight human serum proteome. Mol Cell Proteomics2:1096-1103.
62.
TishlerMYaronIShiraziIYossipovYYaronM (1999). Increased salivary interleukin-6 levels in patients with primary Sjögren’s syndrome. Rheumatol Int18:125-127.
63.
WalzAStuhlerKWattenbergAHawrankeEMeyerHESchmalzG. (2006). Proteome analysis of glandular parotid and sub-mandibular saliva in comparison to whole human saliva by two-dimensional gel electrophoresis. Proteomics6:1631-1639.
WilmarthPARiviereMARustvoldDLLautenJDMaddenTEDavidLL (2005). Two-dimensional liquid chromatography study of the human whole saliva proteome. J Proteome Res3:1017-1023.
66.
XieHRhodusNLGriffinRJCarlisJVGriffinTJ (2005). A catalogue of human saliva proteins identified by free flow electrophoresis based peptide separation and tandem mass spectrometry. Mol Cell Proteomics4:1826-1830.
67.
YanWApweilerRBalgleyBMBoontheungPBundyJLCargileBJ. (2009). Systematic comparison of the human saliva and plasma proteomes. Proteomics Clin Appl3:116-134.
68.
YavuzSTokerEBicakcigilMMumcuGCakirS (2006). Comparative analysis of autoantibodies against α-fodrin in serum, tear fluid, and saliva from patients with Sjögren’s syndrome. J Rheumatol33:1289-1292.
69.
ZhongLPChenGFXuZFZhangXPingFYZhaoSF (2005). Detection of telomerase activity in saliva from oral squamous cell carcinoma patients. Int J Oral Maxillofac Surg34:566-570.
